MX2009010808A - Formulaciones de ansamicina de hidroquinona. - Google Patents

Formulaciones de ansamicina de hidroquinona.

Info

Publication number
MX2009010808A
MX2009010808A MX2009010808A MX2009010808A MX2009010808A MX 2009010808 A MX2009010808 A MX 2009010808A MX 2009010808 A MX2009010808 A MX 2009010808A MX 2009010808 A MX2009010808 A MX 2009010808A MX 2009010808 A MX2009010808 A MX 2009010808A
Authority
MX
Mexico
Prior art keywords
hydroquinone ansamycin
formulations
hydroquinone
ansamycin formulations
compositions
Prior art date
Application number
MX2009010808A
Other languages
English (en)
Inventor
James R Porter
James L Wright
Original Assignee
Infinity Discovery Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Infinity Discovery Inc filed Critical Infinity Discovery Inc
Publication of MX2009010808A publication Critical patent/MX2009010808A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016Disaccharides, e.g. lactose, lactulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)

Abstract

Se proporcionan composiciones farmacéuticas de análogos de geldanamicina de hidroquinona, y usos de dichas composiciones.
MX2009010808A 2007-04-12 2008-04-11 Formulaciones de ansamicina de hidroquinona. MX2009010808A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US91133007P 2007-04-12 2007-04-12
PCT/US2008/060063 WO2008128063A1 (en) 2007-04-12 2008-04-11 Hydroquinone ansamycin formulations

Publications (1)

Publication Number Publication Date
MX2009010808A true MX2009010808A (es) 2009-10-29

Family

ID=39628966

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009010808A MX2009010808A (es) 2007-04-12 2008-04-11 Formulaciones de ansamicina de hidroquinona.

Country Status (10)

Country Link
US (1) US20080255080A1 (es)
EP (1) EP2134338A1 (es)
JP (1) JP2010523710A (es)
CN (1) CN101677991A (es)
AU (1) AU2008240179A1 (es)
BR (1) BRPI0810835A2 (es)
CA (1) CA2684211A1 (es)
IL (1) IL201283A0 (es)
MX (1) MX2009010808A (es)
WO (1) WO2008128063A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7282493B2 (en) 2003-12-23 2007-10-16 Infinity Pharmaceuticals, Inc. Analogs of benzoquinone-containing ansamycins and methods of use thereof
CN102245021B (zh) * 2008-10-15 2014-09-17 无限药品公司 安莎霉素氢醌组合物
CN115227692A (zh) * 2022-09-05 2022-10-25 中国医学科学院基础医学研究所 Reblastatin在制备治疗慢性惊厥的药物中的用途

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4261989A (en) * 1979-02-19 1981-04-14 Kaken Chemical Co. Ltd. Geldanamycin derivatives and antitumor drug
US4762857A (en) * 1986-05-30 1988-08-09 E. I. Du Pont De Nemours And Company Trehalose as stabilizer and tableting excipient
US5387584A (en) * 1993-04-07 1995-02-07 Pfizer Inc. Bicyclic ansamycins
US5932566A (en) * 1994-06-16 1999-08-03 Pfizer Inc. Ansamycin derivatives as antioncogene and anticancer agents
CA2223921A1 (en) * 1995-06-07 1996-12-19 Francis C. Szoka, Jr. Stabilization of polynucleotide complexes
MY120063A (en) * 1997-12-09 2005-08-30 Lilly Co Eli Stabilized teriparatide solutions
DE69907155T2 (de) * 1998-02-18 2004-02-05 Theryte Ltd. Krebsbehandlung
PT1373215E (pt) * 2001-03-30 2006-12-29 Uni S Of A R By The S D Of H H Derivado de geldanamicina e metodo de tratamento de cancro utilizando o mesmo
US6872715B2 (en) * 2001-08-06 2005-03-29 Kosan Biosciences, Inc. Benzoquinone ansamycins
US7465718B2 (en) * 2002-02-08 2008-12-16 Conforma Therapeutics Corporation Ansamycins having improved pharmacological and biological properties
DK2283856T3 (da) * 2002-06-21 2017-11-20 Novo Nordisk Healthcare Ag Stabiliserede, faste sammensætninger af Faktor VIIa-polypeptider
US7282493B2 (en) * 2003-12-23 2007-10-16 Infinity Pharmaceuticals, Inc. Analogs of benzoquinone-containing ansamycins and methods of use thereof
US20060019941A1 (en) * 2003-12-23 2006-01-26 Infinity Pharmaceuticals, Inc. Analogs of benzoquinone-containing ansamycins and methods of use thereof
US20070048323A1 (en) * 2004-02-20 2007-03-01 Rubin J P Antibody treatment of lipomatous tumors
EP1863769A4 (en) * 2005-03-11 2009-03-18 Univ Colorado HSP90 INHIBITORS, METHOD FOR THE PRODUCTION THEREOF AND THEIR APPLICATIONS
JP2008543941A (ja) * 2005-06-21 2008-12-04 インフィニティ・ディスカバリー・インコーポレイテッド アンサマイシン製剤およびその使用方法
CN101360492A (zh) * 2005-12-01 2009-02-04 康福玛医药公司 含安莎霉素的组合物
EP2526933B1 (en) * 2006-09-22 2015-02-25 Pharmacyclics, Inc. Inhibitors of Bruton's tyrosine kinase

Also Published As

Publication number Publication date
CA2684211A1 (en) 2008-10-23
CN101677991A (zh) 2010-03-24
JP2010523710A (ja) 2010-07-15
WO2008128063A1 (en) 2008-10-23
IL201283A0 (en) 2010-05-31
BRPI0810835A2 (pt) 2015-06-16
EP2134338A1 (en) 2009-12-23
AU2008240179A1 (en) 2008-10-23
US20080255080A1 (en) 2008-10-16

Similar Documents

Publication Publication Date Title
MX2012003389A (es) Moduladores de gpr40 de pirrolidina.
MY153915A (en) Organic compounds
UA94833C2 (en) Substituted bicyclolactams
MX2010003599A (es) Intermediarios y metodos para la sintesis de analogos de halicondrina b.
MX2009013830A (es) Compuestos antivirales.
MX2009013827A (es) Compuestos antivirales.
MX346608B (es) Compuestos de isoindol 5-sustituidos.
IN2012DN02984A (es)
MX341825B (es) Compuestos de heteroarilo y usos de los mismos.
MX2012007375A (es) 3-ceto-n-propargil 1-aminoindano.
MX2010007587A (es) Compuestos que comprenden un grupo ciclobutoxi.
MX2010010508A (es) Composiciones de absorcion de sebo.
MY162312A (en) Synthesis of 18f-radiolabeled styrylpyridines from tosylate precersors and stable pharmaceutical compositions thereof
RS20080304A (en) Substituted imidazoles and their use as pesticides
MY151986A (en) Adamantyl diamide derivatives and uses of same
UA104885C2 (uk) Ізотіазолілоксифеніламідини та їх застосування як фунгіцидів
MX2009013354A (es) Compuestos de triarilo y composiciones que los contienen.
MX2009004862A (es) Estabilizacion de vacunas por liofilizacion.
IN2012DN03182A (es)
TW200738649A (en) Calcilytic compounds
MX2010009860A (es) Sintesis total de salinosporamida a y sus analogos.
TW200738627A (en) Trialkylsilyl-indoles
MX2010004487A (es) Derivados lactamicos sustituidos y sus usos para glaucoma e hipertension ocular.
MX2009008028A (es) Agentes antiparasitarios.
MX2009007764A (es) Formulacion de nevirapina de liberacion prolongada.